HYPERLIPIDEMIA
Clinical trials for HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart patients get a digital nudge: app aims to boost Pill-Taking
Disease control ENROLLING_BY_INVITATIONThis study tests a smartphone app called MED-AD to see if it helps people with heart disease take their medications as prescribed. About 1000 adults in Oman will either use the app, get daily text reminders, or receive standard care. The goal is to improve medication adherence an…
Matched conditions: HYPERLIPIDEMIA
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Helping with food and housing may improve diabetes and heart health
Disease control ENROLLING_BY_INVITATIONThis study looks at whether helping adults with type 2 diabetes and high blood pressure or high cholesterol meet their social needs (like food, housing, or transportation) can improve their health. About 4,800 participants will be screened during clinic visits and offered support…
Matched conditions: HYPERLIPIDEMIA
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Lifesaving drug made available for rare fat disorder patients
Disease control OngoingThis study gives the drug metreleptin to people with generalized lipodystrophy, a rare condition that causes severe fat loss and leads to diabetes and high blood fats. Participants, aged 6 months and older, have already received metreleptin in past NIH studies but cannot get it i…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Hope for rare fat disorder: drug keeps working in Long-Term study
Disease control OngoingThis study gives the drug metreleptin to people with partial lipodystrophy, a rare condition that causes abnormal fat storage, high blood fats, and diabetes. Participants have already shown improvement from metreleptin in earlier studies and cannot get the drug elsewhere. The goa…
Matched conditions: HYPERLIPIDEMIA
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Handheld scanners could spot silent killers before symptoms start
Diagnosis ENROLLING_BY_INVITATIONThis study tests if portable devices like handheld ultrasound and blood glucose monitors can find chronic diseases such as diabetes, heart disease, and kidney disease earlier than standard care. About 200 adults aged 18 to 75 will use these devices or receive usual care for 6 mon…
Matched conditions: HYPERLIPIDEMIA
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated May 26, 2026 07:22 UTC